Novartis: Lancet publishes pioneering study of Aimovig’s efficacy in episodic migraine patients

October 27, 2018
0

Novartis announced today that the full data from the LIBERTY study of Aimovig (erenumab) in episodic migraine patients who had tried and failed two to four prior preventive treatments have been published in the Lancet.

Source link

Early Antibiotics and Childhood Obesity: Do Future Risks Matter to Parents and Physicians?

How hibernators could help humans treat illness, conserve energy and get to Mars

You may also like

Sports-Related Concussion: Neurometabolic Aspects.

February 15, 2019
0

Related Articles Sports-Related

Read more

Prevalence and Characteristics of Restless Legs Syndrome in Korean Adults: A Study in Two Independent Samples of the General Population.

February 15, 2019
0

Related Articles Prevalence and

Read more